Literature DB >> 33437363

Correlation of Hypoxia-inducible facto-1α and C-reactive protein with disease evaluation in patients with ulcerative colitis.

Shuxia Yu1, Bin Li2, Jinghua Hao2, Xiuju Shi2, Jian Ge2, Hongwei Xu1,2.   

Abstract

OBJECTIVE: To investigate the expression levels of hypoxia-inducible factor-1α (HIF-1α) and C-reactive protein (CRP) in patients with ulcerative colitis and correlations of HIF-1α and CRP levels with disease severity.
METHODS: A total of 82 patients with confirmed ulcerative colitis were enrolled in this study and according to the disease severity grading, these patients were assigned into three groups: mild group (n=25), moderate group (n=31) and severe group (n=26). And other 30 patients without ulcerative colitis as demonstrated by colonoscopy examination were enrolled in control group in the same period. HIF-1α and CRP levels were detected by ELISA and Real-time PCR and compared among different groups. Pearson's correlation analysis was performed to evaluate the correlations of HIF-1α and CRP levels with disease severity. Logistic regression analysis was used to explore risk factors of disease severity in patients with ulcerative colitis.
RESULTS: The expression levels of HIF-1α and CRP in ulcerative colitis group were significantly higher than those in control group (all P<0.001). The levels of HIF-1α and CRP in patients with ulcerative colitis increased remarkably with the increase of disease severity. Patients in mild group had the lowest levels of HIF-1α and CRP, while patients in severe group had the highest levels of HIF-1α and CRP. Logistic regression analysis showed that the expression of HIF-1α and CRP were the risk factors for disease severity of ulcerative colitis (all P<0.001). And Pearson correlation analysis showed that HIF-1α and CRP levels were significantly associated with Rachmilewitz score and disease activity index (DAI), respectively (all P<0.001).
CONCLUSION: The levels of HIF-1α and CRP were up-regulated in patients with ulcerative colitis and positively correlated with the progression of ulcerative colitis, indicating that the detection of HIF-1α and CRP expression could be used for predicting the disease severity. AJTR
Copyright © 2020.

Entities:  

Keywords:  C-reactive protein; Ulcerative colitis; correlation; hypoxia-inducible factor

Year:  2020        PMID: 33437363      PMCID: PMC7791512     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  31 in total

1.  Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease.

Authors:  Peng Chen; Ying Li; Li Li; Qiao Yu; Kang Chao; Gaoshi Zhou; Yun Qiu; Rui Feng; Shanshan Huang; Yao He; Baili Chen; Minhu Chen; Zhirong Zeng; Shenghong Zhang
Journal:  Aliment Pharmacol Ther       Date:  2019-02-07       Impact factor: 8.171

Review 2.  HIF-1 at the crossroads of hypoxia, inflammation, and cancer.

Authors:  Kuppusamy Balamurugan
Journal:  Int J Cancer       Date:  2015-04-07       Impact factor: 7.396

3.  Clinical evaluation of the intestinal microcirculation using sidestream dark field imaging--recommendations of a round table meeting.

Authors:  Ch Lehmann; I Abdo; H Kern; L Maddison; D Pavlovic; N Sharawi; J Starkopf; R Hall; P Johnson; L Williams; V Cerny
Journal:  Clin Hemorheol Microcirc       Date:  2014       Impact factor: 2.375

Review 4.  Signaling Pathways in Inflammation and Anti-inflammatory Therapies.

Authors:  Yiu To Yeung; Faisal Aziz; Angelica Guerrero-Castilla; Sandro Arguelles
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

5.  Correlation of C-reactive protein with clinical and endoscopic activity in patients with ulcerative colitis.

Authors:  Sami Karoui; Sonia Laz; Meriem Serghini; Norsaf Bibani; Jalel Boubaker; Azza Filali
Journal:  Dig Dis Sci       Date:  2010-12-03       Impact factor: 3.199

Review 6.  Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein.

Authors:  Mariame Moutachakkir; Asma Lamrani Hanchi; Azzedine Baraou; Abderrahman Boukhira; Saliha Chellak
Journal:  Ann Biol Clin (Paris)       Date:  2017-04-01       Impact factor: 0.459

7.  Increased expression of vascular endothelial growth factor and hypoxia inducible factor-1α in lung tissue of patients with chronic bronchitis.

Authors:  Seung Hyeun Lee; Sang Hoon Lee; Chul Hwan Kim; Kyung Suk Yang; Eun Joo Lee; Kyung Hoon Min; Gyu Young Hur; Seung Heon Lee; Sung Yong Lee; Je Hyeong Kim; Chol Shin; Jae Jeong Shim; Kwang Ho In; Kyung Ho Kang; Sang Yeub Lee
Journal:  Clin Biochem       Date:  2014-01-21       Impact factor: 3.281

8.  Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.

Authors:  Taro Osada; Toshifumi Ohkusa; Isao Okayasu; Tsutomu Yoshida; Shu Hirai; Kazuko Beppu; Tomoyoshi Shibuya; Naoto Sakamoto; Osamu Kobayashi; Akihito Nagahara; Takeshi Terai; Sumio Watanabe
Journal:  J Gastroenterol Hepatol       Date:  2008-12       Impact factor: 4.029

Review 9.  Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.

Authors:  Nadia Mohammed Vashist; Mark Samaan; Mahmoud H Mosli; Claire E Parker; John K MacDonald; Sigrid A Nelson; G Y Zou; Brian G Feagan; Reena Khanna; Vipul Jairath
Journal:  Cochrane Database Syst Rev       Date:  2018-01-16

10.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.

Authors:  Fernando Magro; Paolo Gionchetti; Rami Eliakim; Sandro Ardizzone; Alessandro Armuzzi; Manuel Barreiro-de Acosta; Johan Burisch; Krisztina B Gecse; Ailsa L Hart; Pieter Hindryckx; Cord Langner; Jimmy K Limdi; Gianluca Pellino; Edyta Zagórowicz; Tim Raine; Marcus Harbord; Florian Rieder
Journal:  J Crohns Colitis       Date:  2017-06-01       Impact factor: 10.020

View more
  2 in total

1.  Enhanced oxidative phosphorylation of IgG plasma cells can contribute to hypoxia in the mucosa of active ulcerative colitis.

Authors:  Yoshihiro Nagase; Makoto Kodama; Keiko Abe; Masayuki Fukata; Tetsuo Yamana; Nobuyuki Igarashi
Journal:  Histochem Cell Biol       Date:  2022-06-18       Impact factor: 2.531

2.  Artificial Neural Network Analysis-Based Immune-Related Signatures of Primary Non-Response to Infliximab in Patients With Ulcerative Colitis.

Authors:  Xuanfu Chen; Lingjuan Jiang; Wei Han; Xiaoyin Bai; Gechong Ruan; Mingyue Guo; Runing Zhou; Haozheng Liang; Hong Yang; Jiaming Qian
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.